- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07723768
Neuromuscular and Structural Effects of Using Stretching During the Recovery Phase Between Sets of Upper and Lower-body Strength Training
Efectos Neuromusculares y Estructurales de la utilización de Estiramientos en la Fase de recuperación Entre Series de Entrenamiento de la Fuerza de Los Miembros Superiores e Inferiores
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
- Altro: Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
- Altro: Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
- Altro: Neuromuscular and structural effects of using NOT stretching during the recovery phase between sets of upper and lower-body strength training
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Madrid
-
Villaviciosa de Odón, Madrid, Spagna
- Edificio D
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
Male or female adults aged 18-30 years. Apparently healthy, with no medical conditions that contraindicate participation in resistance training.
A minimum of 6 consecutive months of resistance training experience. Regular resistance training participation of at least three sessions per week during the previous 6 months.
Previous experience performing the back squat and bench press exercises with correct technique.
Ability to perform maximal intended concentric velocity during resistance exercises.
Willingness to refrain from vigorous physical activity during the 24 hours preceding each testing and training session.
Ability and willingness to comply with all study procedures. Provision of written informed consent.
Exclusion Criteria:
Current musculoskeletal injury affecting the upper or lower limbs that limits participation in resistance training or testing.
Acute or chronic pain that is aggravated by the study exercises. Cardiovascular, neurological, metabolic, or other medical conditions that contraindicate vigorous physical exercise.
Current participation in another structured intervention study or clinical trial.
Inability to attend the scheduled assessments or training sessions. Failure to comply with the study protocol or training requirements. Withdrawal of informed consent at any stage of the study. Occurrence of an adverse event during the intervention that prevents continued participation.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Agonists stretching
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Altri nomi:
|
|
Comparatore attivo: Antagonists stretching
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Altri nomi:
|
|
Comparatore placebo: Control
Neuromuscular and structural effects of NOT using stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using NOT stretching during the recovery phase between sets of upper and lower-body strength training
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Acute resistance-training performance: total number of repetitions
Lasso di tempo: First intervention session (Week 1), across the four training sets.
|
Total number of repetitions completed across four sets of bench press and back squat during the first intervention session.
Participants will perform each set to momentary muscular failure at maximal intended concentric velocity, using individualized absolute loads corresponding to 75% of the estimated one-repetition maximum (1RM) for the bench press and 80% of the estimated 1RM for the back squat.
Repetitions completed in each set and total repetitions per exercise will be recorded to compare the immediate effects of agonist stretching, antagonist stretching, and no stretching.
|
First intervention session (Week 1), across the four training sets.
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- 2024-495
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .